Codexis (CDXS) has disclosed a new risk, in the Capital Markets category.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Codexis faces significant business risks due to international trade policies, including tariffs, sanctions, and trade barriers, which could adversely impact its operations. The global economy’s inherent uncertainties, coupled with recent U.S. government tariffs and retaliatory measures by foreign governments, pose challenges to Codexis’s supply chain and cost structure. These developments may increase research and development expenses, disrupt supply chains, and place Codexis at a competitive disadvantage compared to companies in regions with more favorable trade relationships. The ongoing uncertainty in international trade policies could materially affect Codexis’s business, financial condition, and competitive position.
Overall, Wall Street has a Strong Buy consensus rating on CDXS stock based on 4 Buys and 1 Hold.
To learn more about Codexis’ risk factors, click here.